JEVERIA ALI: Open Payments
NPI 1396456505 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$473 in 15 payments from 13 companies in 2025. Trend: 2023 $223 · 2024 $167 · 2025 $473
Food & beverage: $473
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $189 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $42 |
| Averitas Pharma Inc. | 1 | $32 |
| Lilly USA, LLC | 1 | $27 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Tandem Diabetes Care, Inc. | 1 | $24 |
| Eisai Inc. | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Edwards Lifesciences Corporation | 1 | $22 |
| Novo Nordisk Inc | 1 | $20 |
Products named: TEPEZZA, LifeVest, QUTENZA, JARDIANCE, LEQVIO, t:slim X2 Insulin Pump with Control-IQ, Leqembi, TRELEGY ELLIPTA.
Industry payments across FL — which companies pay providers there.
